Genome-based bioprospecting of microbes for new therapeutics

Current Opinion in Biotechnology
Sergey B ZotchevLeonard Katz

Abstract

Bioprospecting of natural sources for new medicines has a long and successful history, exemplified by the fact that over 50% of all drugs currently on the market are either derived from or inspired by natural products. However, development of new natural product-based therapeutics has been on the decline over the past 20 years, mainly owing to frequent re-discovery of already known compounds coupled with high costs for screening, characterization and development. With the onset of the genomic era allowing rapid sequencing and analysis of bacterial and fungal genomes, it became evident that these organisms possess 'hidden treasures' in the form of gene clusters potentially governing biosynthesis of novel biologically active compounds. This review highlights current progress in mining for and expression of these gene clusters, which may revolutionize the drug discovery pipelines in the near future.

References

Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·V LarionovM A Resnick
Jan 22, 2003·Nature Biotechnology·Emmanuel ZazopoulosChris M Farnet
Jan 21, 2006·FEMS Yeast Research·Sarah C MutkaJames T Kealey
Feb 13, 2007·Nature Methods·Mamie Z Li, Stephen J Elledge
Dec 11, 2007·Nature Methods·Mitsuhiro ItayaKenji Tsuge
Apr 16, 2008·Journal of Biological Engineering·Reshma P ShettyThomas F Knight
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Daniel G GibsonClyde A Hutchison
Dec 17, 2008·Nucleic Acids Research·Zengyi ShaoHuimin Zhao
Apr 14, 2009·Nature Methods·Daniel G GibsonHamilton O Smith
May 5, 2009·Nature Methods·Christoph BieniossekImre Berger
Oct 6, 2009·Nature Biotechnology·Howard M SalisChristopher A Voigt
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mamoru KomatsuHaruo Ikeda
Mar 9, 2010·Journal of Biological Engineering·J Christopher AndersonJay D Keasling
May 15, 2010·Journal of Industrial Microbiology & Biotechnology·Richard H Baltz
Dec 30, 2010·Nature Reviews. Microbiology·Marnix H MedemaEriko Takano
Feb 24, 2011·Microbial Biotechnology·Juan Pablo Gomez-Escribano, Mervyn J Bibb
Mar 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Luisa LauretiBertrand Aigle
Sep 10, 2011·Proceedings of the National Academy of Sciences of the United States of America·Takeshi MurakamiCharles J Thompson
Oct 11, 2011·Nature Chemical Biology·Roland D KerstenPieter C Dorrestein
Jan 14, 2012·Nucleic Acids Research·Yongwei ZhangWinfried Edelmann
Jan 17, 2012·Applied and Environmental Microbiology·Simone HerrmannAndriy Luzhetskyy
Jan 24, 2012·Nature Reviews. Microbiology·Marnix H MedemaRainer Breitling

❮ Previous
Next ❯

Citations

Dec 25, 2012·Nucleic Acids Research·Jing LiangHuimin Zhao
Jun 6, 2013·Nucleic Acids Research·Kai BlinTilmann Weber
Oct 15, 2013·International Journal of Medical Microbiology : IJMM·Sacha J PidotChristian Hertweck
Nov 12, 2013·Journal of Industrial Microbiology & Biotechnology·Xiangyang Liu, Yi-Qiang Cheng
Oct 16, 2013·Journal of Industrial Microbiology & Biotechnology·Maria I VizcainoJason M Crawford
Oct 16, 2013·Journal of Industrial Microbiology & Biotechnology·Yuriy RebetsAndriy Luzhetskyy
Mar 14, 2013·Expert Opinion on Drug Discovery·Herbert A Kirst
Oct 22, 2015·ACS Chemical Biology·Natalia A JungmannRoderich D Süssmuth
Apr 26, 2014·Current Opinion in Biotechnology·Eric J N HelfrichJörn Piel
Aug 21, 2013·Biotechnology and Bioengineering·Thomas C ScanlonKarl E Griswold
Apr 2, 2013·Current Opinion in Biotechnology·Hans-Jörg FraschRainer Breitling
Apr 29, 2015·Frontiers in Plant Science·Walaa K Mousa, Manish N Raizada
Jun 5, 2013·Current Opinion in Biotechnology·Michael M Schofield, David H Sherman
Sep 5, 2014·PLoS Computational Biology·Marnix H MedemaRainer Breitling
Mar 16, 2016·Beilstein Journal of Organic Chemistry·Christine BeemelmannsMichael Poulsen
Nov 28, 2017·Applied Microbiology and Biotechnology·Bhupendra S PanwarSarvjeet Kaur
Feb 7, 2014·Journal of Natural Products·Gordon M CraggDavid J Newman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomaterial Engineering

Advances in biomaterial engineering have permitted the development of sophisticated drug-releasing materials with a biomimetic 3D support that allow a better control of the microenvironment of transplanted cells. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Molecular Biology and Evolution
Marnix H MedemaRainer Breitling
Current Opinion in Chemical Biology
Siying MaJingdong Tian
Integrative Biology : Quantitative Biosciences From Nano to Macro
Tom EllisGeoff S Baldwin
© 2021 Meta ULC. All rights reserved